Medtronic has won Food and Drug Administration approval for the Omniasecure defibrillation lead, the company said Friday. The lead connects to an implantable defibrillator and treats potentially ...

Medtronic is seeking regulatory clearance for an insulin pump that could expand its partnership with Abbott. In its application to the Food and Drug Administration, Medtronic is seeking clearance ...

Medtronic’s top ventilator executive began fielding pleas from world leaders’ representatives five years ago, as pressure from a global pandemic drove a sudden shortage of lifesaving devices ...

VCG / Contributor / Getty Images Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts. The revenue miss came as sales of its stapling and blood oxygen management ...

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision. The group at the time was ...

Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue ...

Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps ...

He succeeds Michael Blackwell who has moved back to the US to pursue new opportunities, a note from the company said. Also read: Medtronic to invest ₹3,000 cr in Hyderabad centre Mandeep Singh ...

India Medtronic, a subsidiary of Medtronic plc, announced the appointment of Mandeep Singh Kumar as the new vice president and managing director of the company, effective May 2024. He replaces Michael ...

he succeeds Michael Blackwell who has moved back to the US to pursue new opportunities. Assuming this position, he will oversee sales, marketing, and commercial operations for Medtronic’s ...

Medtronic beat on sales and earnings and gave exactly the guidance that Wall Street expected. Its stock dropped today anyway. Why? Because Medtronic stock costs too much. Heading into earnings ...

Medtronic said Friday that the U.S. Food and Drug Administration has approved a new spinal-cord implant that relieves chronic pain, a bid to expand into a patient population that relies heavily on ...